US Patent Issued to BOEHRINGER INGELHEIM ANIMAL HEALTH USA on June 30 for "Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,556, issued on June 30, was assigned to BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. (Duluth, Ga.).

"Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof" was invented by Susan Mancini Cady (Yardley, Pa.), Peter Cheifetz (East Windsor, N.J.), Izabela Galeska (Newtown, Pa.) and Loic Patrick Le Hir de Fallois (Hopewell, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to extended release injectable formulations for combating parasites in animals, comprising at least one isoxazoline active agent, a pharmaceutically acceptable polymer, and a solvent. This invention also provid...